Europe Nerve Repair & Regeneration Market by Types (Neurostimulation, Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), Procedures (Direct Nerve Repair, Nerve Grafting, Neuromodulation Surgery, Stem Cell Therapy) - Forecast to 2019
The European nerve repair and regeneration market comprises various types of products that can be segmented into nerve repair by biomaterials and nerve repair by neurostimulation, of which nerve repair by neurostimulation holds the highest market share of 66.4%, followed by nerve repair by biomaterials with a market share of 33.6%.
The European nerve repair and regeneration market displays growth that is projected to grow at a CAGR of 11.9% by 2019. This growth is driven by a number of drivers such as technological advancements and increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market.
In the European region, the maximum market share is held by Germany and France; there has been a growth trend in this region over the past few years, due to the increasing diseases related to nerves such as Parkinson’s and epilepsy, as these are the major application areas for the devices; however, nerve repair by neurostimulation is widely used. The report focuses on an in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas.
Technological advancements have been a backbone in increasing the market, which has been deeply analysed and added in the report. Due to the increasing demand and potential for these devices, the government has also extended its support; however, some stringent rules and regulations such as the implementation of taxes may still hamper the growth in the market.
A competitive analysis of the reports has been provided on the basis of companies that have been worked through diagrams and pie charts. It involves leaders such as Integra life sciences Corporation, Axogen, Stryker, Baxter International Inc., etc.
The European nerve repair and regeneration market displays growth that is projected to grow at a CAGR of 11.9% by 2019. This growth is driven by a number of drivers such as technological advancements and increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market.
In the European region, the maximum market share is held by Germany and France; there has been a growth trend in this region over the past few years, due to the increasing diseases related to nerves such as Parkinson’s and epilepsy, as these are the major application areas for the devices; however, nerve repair by neurostimulation is widely used. The report focuses on an in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas.
Technological advancements have been a backbone in increasing the market, which has been deeply analysed and added in the report. Due to the increasing demand and potential for these devices, the government has also extended its support; however, some stringent rules and regulations such as the implementation of taxes may still hamper the growth in the market.
A competitive analysis of the reports has been provided on the basis of companies that have been worked through diagrams and pie charts. It involves leaders such as Integra life sciences Corporation, Axogen, Stryker, Baxter International Inc., etc.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE NERVE REPAIR AND REGENERATION MARKET
2.1.1 TOP-DOWN APPROACH
2.1.2 BOTTOM-UP APPROACH
2.1.3 MACRO INDICATOR-BASED APPROACH
2.2 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 NERVE REPAIR AND REGENERATION MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 NERVE REPAIR AND REGENERATION MARKET, BY TYPE
5.1 INTRODUCTION
5.2 NERVE REPAIR AND REGENERATION MARKET, TYPE COMPARISON WITH PARENT MARKET
5.3 EUROPE NERVE REPAIR BY BIOMATERIALS, BY GEOGRAPHY
5.4 EUROPE NERVE REPAIR BY NEUROSTIMULATION, BY GEOGRAPHY
6 NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY
6.1 INTRODUCTION
6.2 GERMANY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.3 FRANCE: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.4 U.K.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.5 ITALY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.6 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
7 NERVE REPAIR AND REGENERATION MARKET: COMPETITIVE LANDSCAPE
7.1 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 EXPANSIONS
8 NERVE REPAIR AND REGENERATION MARKET, BY COMPANY
8.1 INTEGRA LIFE SCIENCES CORP.
8.1.1 OVERVIEW
8.1.2 KEY FINANCIALS
8.1.3 PRODUCT AND SERVICE OFFERINGS
8.1.4 RELATED DEVELOPMENTS
8.2 AXOGEN, INC.
8.2.1 OVERVIEW
8.2.2 KEY FINANCIALS
8.2.3 PRODUCT AND SERVICE OFFERINGS
8.2.4 RELATED DEVELOPMENTS
8.3 POLYGANICS.
8.3.1 OVERVIEW
8.3.2 KEY FINANCIALS
8.3.3 PRODUCT AND SERVICE OFFERINGS
8.3.4 RELATED DEVELOPMENTS
8.4 STRYKER
8.4.1 OVERVIEW
8.4.2 KEY FINANCIALS
8.4.3 PRODUCT AND SERVICE OFFERINGS
8.4.4 RELATED DEVELOPMENTS
8.5 ST. JUDE MEDICAL
8.5.1 OVERVIEW
8.5.2 KEY FINANCIALS
8.5.3 PRODUCT AND SERVICE OFFERINGS
8.5.4 RELATED DEVELOPMENTS
8.6 MEDTRONIC PLC
8.6.1 OVERVIEW
8.6.2 KEY FINANCIALS
8.6.3 PRODUCT AND SERVICE OFFERINGS
8.6.4 RELATED DEVELOPMENTS
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 TECHNICAL ANALYSIS
9.1.2 LOW-COST SOURCING LOCATIONS
9.1.3 REGULATORY FRAMEWORK
9.1.4 IMPACT ANALYSIS
9.1.5 HISTORICAL DATA AND TRENDS
9.2 RELATED REPORTS
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE NERVE REPAIR AND REGENERATION MARKET
2.1.1 TOP-DOWN APPROACH
2.1.2 BOTTOM-UP APPROACH
2.1.3 MACRO INDICATOR-BASED APPROACH
2.2 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 NERVE REPAIR AND REGENERATION MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 NERVE REPAIR AND REGENERATION MARKET, BY TYPE
5.1 INTRODUCTION
5.2 NERVE REPAIR AND REGENERATION MARKET, TYPE COMPARISON WITH PARENT MARKET
5.3 EUROPE NERVE REPAIR BY BIOMATERIALS, BY GEOGRAPHY
5.4 EUROPE NERVE REPAIR BY NEUROSTIMULATION, BY GEOGRAPHY
6 NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY
6.1 INTRODUCTION
6.2 GERMANY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.3 FRANCE: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.4 U.K.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.5 ITALY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
6.6 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE
7 NERVE REPAIR AND REGENERATION MARKET: COMPETITIVE LANDSCAPE
7.1 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS
7.2 MERGERS & ACQUISITIONS
7.3 EXPANSIONS
8 NERVE REPAIR AND REGENERATION MARKET, BY COMPANY
8.1 INTEGRA LIFE SCIENCES CORP.
8.1.1 OVERVIEW
8.1.2 KEY FINANCIALS
8.1.3 PRODUCT AND SERVICE OFFERINGS
8.1.4 RELATED DEVELOPMENTS
8.2 AXOGEN, INC.
8.2.1 OVERVIEW
8.2.2 KEY FINANCIALS
8.2.3 PRODUCT AND SERVICE OFFERINGS
8.2.4 RELATED DEVELOPMENTS
8.3 POLYGANICS.
8.3.1 OVERVIEW
8.3.2 KEY FINANCIALS
8.3.3 PRODUCT AND SERVICE OFFERINGS
8.3.4 RELATED DEVELOPMENTS
8.4 STRYKER
8.4.1 OVERVIEW
8.4.2 KEY FINANCIALS
8.4.3 PRODUCT AND SERVICE OFFERINGS
8.4.4 RELATED DEVELOPMENTS
8.5 ST. JUDE MEDICAL
8.5.1 OVERVIEW
8.5.2 KEY FINANCIALS
8.5.3 PRODUCT AND SERVICE OFFERINGS
8.5.4 RELATED DEVELOPMENTS
8.6 MEDTRONIC PLC
8.6.1 OVERVIEW
8.6.2 KEY FINANCIALS
8.6.3 PRODUCT AND SERVICE OFFERINGS
8.6.4 RELATED DEVELOPMENTS
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 TECHNICAL ANALYSIS
9.1.2 LOW-COST SOURCING LOCATIONS
9.1.3 REGULATORY FRAMEWORK
9.1.4 IMPACT ANALYSIS
9.1.5 HISTORICAL DATA AND TRENDS
9.2 RELATED REPORTS
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
LIST OF TABLES
Table 1 EUROPE NERVE REPAIR AND REGENERATION MARKET: HEALTHCARE EXPENDITURE, BY GEOGRAPHY, 2014
Table 2 NERVE REPAIR AND REGENERATION: COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
Table 3 EUROPE NERVE REPAIR & REGENERATION MARKET DRIVERS AND INHIBITORS
Table 4 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 5 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Table 6 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 7 EUROPE NERVE REPAIR AND REGENERATION MARKET: TYPE COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
Table 8 EUROPE NERVE REPAIR BY BIOMATERIALS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Table 9 EUROPE NERVE REPAIR BY NEUROSTIMULATION, BY GEOGRAPHY, 2013-2019 (USD MN)
Table 10 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Table 11 GERMANY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 12 FRANCE: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013 – 2019 (USD MN)
Table 13 U.K.: NERVE REPAIR AND REGENERATION: MARKET, BY TYPE, 2013-2019 (USD MN)
Table 14 ITALY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 15 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 16 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
Table 17 EUROPE NERVE REPAIR AND REGENERATION MARKET: MERGERS & ACQUISITIONS
Table 18 EUROPE NERVE REPAIR AND REGENERATION MARKET: EXPANSIONS
Table 19 INTEGRA LIFE SCIENCES CORP: KEY FINANCIALS, 2008-2013 (USD MN)
Table 20 AXOGEN, INC: KEY FINANCIALS, 2009-2013 (USD MN)
Table 21 STRYKER: KEY FINANCIALS, BY GEOGRAPHY, 2009 - 2013 (USD MN)
Table 22 ST. JUDE MEDICAL: KEY FINANCIALS, 2009-2013 (USD MN)
Table 23 MEDTRONIC PLC: KEY FINANCIALS, 2009-2013 (USD MN)
Table 1 EUROPE NERVE REPAIR AND REGENERATION MARKET: HEALTHCARE EXPENDITURE, BY GEOGRAPHY, 2014
Table 2 NERVE REPAIR AND REGENERATION: COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
Table 3 EUROPE NERVE REPAIR & REGENERATION MARKET DRIVERS AND INHIBITORS
Table 4 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 5 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Table 6 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 7 EUROPE NERVE REPAIR AND REGENERATION MARKET: TYPE COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
Table 8 EUROPE NERVE REPAIR BY BIOMATERIALS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Table 9 EUROPE NERVE REPAIR BY NEUROSTIMULATION, BY GEOGRAPHY, 2013-2019 (USD MN)
Table 10 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Table 11 GERMANY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 12 FRANCE: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013 – 2019 (USD MN)
Table 13 U.K.: NERVE REPAIR AND REGENERATION: MARKET, BY TYPE, 2013-2019 (USD MN)
Table 14 ITALY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 15 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Table 16 NERVE REPAIR AND REGENERATION MARKET: COMPANY SHARE ANALYSIS, 2013 (%)
Table 17 EUROPE NERVE REPAIR AND REGENERATION MARKET: MERGERS & ACQUISITIONS
Table 18 EUROPE NERVE REPAIR AND REGENERATION MARKET: EXPANSIONS
Table 19 INTEGRA LIFE SCIENCES CORP: KEY FINANCIALS, 2008-2013 (USD MN)
Table 20 AXOGEN, INC: KEY FINANCIALS, 2009-2013 (USD MN)
Table 21 STRYKER: KEY FINANCIALS, BY GEOGRAPHY, 2009 - 2013 (USD MN)
Table 22 ST. JUDE MEDICAL: KEY FINANCIALS, 2009-2013 (USD MN)
Table 23 MEDTRONIC PLC: KEY FINANCIALS, 2009-2013 (USD MN)
LIST OF FIGURES
Figure 1 EUROPE NERVE REPAIR AND REGENERATION MARKET SEGMENTATION & COVERAGE
Figure 2 NERVE REPAIR AND REGENERATION MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 BOTTOM-UP APPROACH
Figure 5 MACRO INDICATOR-BASED APPROACH 2014
Figure 6 EUROPEAN NERVE REPAIR AND REGENERATION MARKET SNAPSHOT - 2014
Figure 7 EUROPE NERVE REPAIR AND REGENERATION TYPES, BY GEOGRAPHY, 2013 (USD MN)
Figure 8 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 9 EUROPE NERVE REPAIR AND REGENERATION MARKET: TYPE COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
Figure 10 EUROPE NERVE REPAIR BY BIOMATERIALS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Figure 11 EUROPE NERVE REPAIR BY NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Figure 12 EUROPEAN NERVE REPAIR AND REGENERATION MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2013-2019 (USD MN)
Figure 13 GERMANY: NERVE REPAIR AND REGENERATION, BY TYPE, 2013-2019 (USD MN)
Figure 14 GERMANY: NERVE REPAIR AND REGENERATION MARKET SHARE, BY TYPE, 2014-2019 (%)
Figure 15 FRANCE: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 16 FRANCE: NERVE REPAIR AND REGENERATION MARKET SHARE, BY TYPE, 2014-2019 (%)
Figure 17 U.K.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 18 U.K.: NERVE REPAIR AND REGENERATION MARKET: TYPE SNAPSHOT 2014 - 2019
Figure 19 ITALY NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 20 ITALY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2014-2019
Figure 21 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 22 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE 2014 & 2019
Figure 23 NERVE REPAIR AND REGENERATION: COMPANY SHARE ANALYSIS, 2013 (%)
Figure 24 INTEGRA LIFE SCIENCES HOLDINGS CORP.: REVENUE MIX, 2013 (%)
Figure 25 CONTRIBUTION OF THE NEUROSURGERY SEGMENT TOWARDS COMPANY REVENUES, 2008-2013 (USD MN)
Figure 26 STRYKER: REVENUE MIX, 2013 (%)
Figure 27 ST. JUDE MEDICAL, REVENUE MIX, 2013 (%)
Figure 28 MEDTRONIC PLC REVENUE MIX 2013 (%)
Figure 1 EUROPE NERVE REPAIR AND REGENERATION MARKET SEGMENTATION & COVERAGE
Figure 2 NERVE REPAIR AND REGENERATION MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 BOTTOM-UP APPROACH
Figure 5 MACRO INDICATOR-BASED APPROACH 2014
Figure 6 EUROPEAN NERVE REPAIR AND REGENERATION MARKET SNAPSHOT - 2014
Figure 7 EUROPE NERVE REPAIR AND REGENERATION TYPES, BY GEOGRAPHY, 2013 (USD MN)
Figure 8 EUROPE NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 9 EUROPE NERVE REPAIR AND REGENERATION MARKET: TYPE COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
Figure 10 EUROPE NERVE REPAIR BY BIOMATERIALS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Figure 11 EUROPE NERVE REPAIR BY NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
Figure 12 EUROPEAN NERVE REPAIR AND REGENERATION MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2013-2019 (USD MN)
Figure 13 GERMANY: NERVE REPAIR AND REGENERATION, BY TYPE, 2013-2019 (USD MN)
Figure 14 GERMANY: NERVE REPAIR AND REGENERATION MARKET SHARE, BY TYPE, 2014-2019 (%)
Figure 15 FRANCE: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 16 FRANCE: NERVE REPAIR AND REGENERATION MARKET SHARE, BY TYPE, 2014-2019 (%)
Figure 17 U.K.: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 18 U.K.: NERVE REPAIR AND REGENERATION MARKET: TYPE SNAPSHOT 2014 - 2019
Figure 19 ITALY NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 20 ITALY: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2014-2019
Figure 21 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE, 2013-2019 (USD MN)
Figure 22 SPAIN: NERVE REPAIR AND REGENERATION MARKET, BY TYPE 2014 & 2019
Figure 23 NERVE REPAIR AND REGENERATION: COMPANY SHARE ANALYSIS, 2013 (%)
Figure 24 INTEGRA LIFE SCIENCES HOLDINGS CORP.: REVENUE MIX, 2013 (%)
Figure 25 CONTRIBUTION OF THE NEUROSURGERY SEGMENT TOWARDS COMPANY REVENUES, 2008-2013 (USD MN)
Figure 26 STRYKER: REVENUE MIX, 2013 (%)
Figure 27 ST. JUDE MEDICAL, REVENUE MIX, 2013 (%)
Figure 28 MEDTRONIC PLC REVENUE MIX 2013 (%)
